Mark J. Krasna

St. Jospeh Cancer Institute, USA

Mark J. Krasna works as a Medical Director at St. Joseph Cancer Institute, and Catholic Health Initiatives (CHI), St. Joseph's parent organization. He is the overall principle investigator for CHI's National Community Cancer Center Program (NCCCP) with the NCI and the The Cancer Genome Atlas contract with NCI. Dr. Krasna serves on the Editorial Boards of Surgical Laparoscopy, and Endoscopy and is Editor-in-Chief of the Journal Of Multidisciplinary Cancer Care. Dr. Krasna worked as a Professor of surgery at the University of Maryland Medical School. He served as an Associate Director for Multidisciplinary Cancer Care and later as an Associate Director for Surgical Oncology at the University of Maryland Greenebaum Cancer Center. Dr. Krasna has mentored physicians from around the world including the US, China, Korea, and Russia. Dr. Krasna served as the Chair of the CALGB Thoracic Surgery Subcommittee and as a Member of the Respiratory and Gastrointestinal (GI) Committees of the CALGB. CALGB 9380 was the first ever phase 2 NCI approved multi-institutional trial to evaluate the role of thoracoscopy or video assisted thoracic surgery (VATS) in the management of thoracic malignancies. Due in part to the success of this trial, Dr. Krasna then led to 9781, a national Phase III trial in esophageal cancer treatment. Dr. Krasna is currently the surgical PI from RTOG. 0229 is a Phase II study for trimodality therapy in NSCLC Stage 3A. He coauthored the 1996 and 2000 Patterns of Care Study (PCS) of the RTOG for esophageal cancer. He is the author of the first Atlas of Thoracoscopic Surgery. Dr. Krasna has served the AATS and ASCO on numerous committees including the membership and CT residents committees and currently serves as the Postgraduate Program Director for the STSA, active in the STS. Dr. Krasna is an Investigator with CTSU, RTOG, and ACOSOG.

Biography Updated on 14 March 2010

Scholarly Contributions [Data Provided by ]